Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 2
62
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and tissue distribution of the nonadecapeptide Moli1901 in rats and mice

, , , , , & show all
Pages 197-210 | Published online: 22 Sep 2008

References

  • CLOUTIER, M. M., GUERNSEY, L., MATTES, P. and KOEPPEN, B., 1990, Duramycin enhances chloride secretion in airway epithelium. American Journal of Physiology, 259, C450—C454.
  • CLOUTIER, M. M., GUERNSEY, L. and SHA'AFI, R. I., 1993, Duramycin increases intracellular calcium in airway epithelium. Membrane Biochemistry, 10, 107–118.
  • DODOO, A. N. O., BANSAL, S., BARLOW, D. J., BENNET, E. C., HIDER, R. C., LANSLEY, A. B., LAWRENCE, M. J. and MARRIOTT, C., 2000, Systemic investigations of the influence of molecular structure on the transport of peptides across cultured alveolar cell monolayers. Pharmaceutical Research, 17, 7–14.
  • FRITSCH, P. and MASSE, R., 1992, Overview of pulmonary alveolar macrophage renewal in normal rats and during different pathological processes. Environmental Health Perspectives, 97, 59–67.
  • GATTO, L. A., 1993, Cholinergic and adrenergic stimulation of mucociliary transport in the rat trachea. Respiration Physiology, 92, 209–217.
  • HAYASHI, F., NAGASHIMA, K., TERUI, Y., KAWAMURA, Y., MATSUMOTO, K. and ITAZAKI, H., 1990, THE STRUCTURE OF PA48009: THE REVISED STRUCTURE OF DURAMYCIN. Journal of Antibiotics, 43, 1421–1430.
  • HENKE, D. C., STUTTS, M. J., HARVEY, R. and MOLINA, L., 1998, Bioelectric and fluid transport effects of the nonadecapeptide 2622U90 (duramycin) in normal human cystic fibrosis airway epithelium and canine airways. Pediatric Pulmonology, suppl. 17, 238.
  • KNOWLES, M. R., CLARKE, L. L. and BOUCHER, R. C., 1991, Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. New England Journal of Medicine, 325, 533–538.
  • MARKI, F., HANNI, E., FREDENHAGEN, A. and VAN OOSTRUM, J., 1991, Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2. Biochemical Pharmacology, 42, 2027–2035.
  • MCNULTY, M. J., HUTABARAT, R. M., HARVEY, R. and MOLINA, L., 1997, The disposition of the nonadecapeptide, duramycin, in the beagle dog after inhalation exposure. ISSX Proceedings, 12, 123.
  • MOLINA Y VEDIA, L., STUTTS, M. J., BOUCHER, R. C. and HENKE, D. C., 1996, Method of treating retained pulmonary secretions. US Patent 5,512,269.
  • NAVARRO, J, CHABOT, J, SHERRILL, K, ANEJA, R, ZAHLER, S. A. and RACKER, E., 1985, Interaction of duramycin with artificial and natural membranes. Biochemistry, 24, 4645–4650.
  • PATTON, J. S. and PLATZ, R. M., 1992, Routes of delivery: case studies. Pulmonary delivery of peptides and proteins for systemic action. Advanced Drug Delivery Reviews, 8, 179–196.
  • ROBERTS, M., HLADKY, S. B., PICKLES, R. J. and CUTHBERT, A. W., 1991, Stimulation of sodium transport by duramycin in cultured human colonic epithelia. Journal of Pharmacology and Experimental Therapeutics, 259, 1050–1058.
  • SHOTVVELL, O. L., STODOLA, F. H., MICHAEL, W. R., LINDENFELSER, L. A., DWORSCHACK, R. G. and PRIDHAM, T. G., 1958, Antibiotics against plant disease III. Duramycin, a new antibiotic from Streptomyces cinnamomeus forma azacoluta. Journal of the American Chemical Society, 80, 3912–3914.
  • SOKOLOVE, P. M., WESTPHAL, P. A., RESTER, M. B., WIERWILLE, R. and SIKORA-VANMETER, K., 1989, Duramycin effects on the structure and function of heart mitochondria. I. Structural alterations and changes in membrane permeability. Biochimica et Biophysica Acta, 983, 15–22.
  • STONE, D. K., XIE, S.-S. and RACKER, E., 1984, Inhibition of clathrin-coated vesicle acidification by duramycin. Journal of Biological Chemistry, 259: 2701–2703.
  • TASK GROUP ON MUCOACTIVE DRUGS, 1994, Special report: Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chromic obstructive pulmonary disease. Chest, 106, 1532–1537.
  • ZEITLIN, P., GUGGINO, W. and MOLINA, L., 1998, Activation by the nonadecapeptide 2622U90 (duramycin) of chloride secretion in healthy volunteers and patients with cystic fibrosis. Pediatric Pulmonology, suppl. 17, 277–278.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.